Sequence-divergent chordopoxvirus homologs of the O3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1696-1705

  Satheshkumar, P S ^a   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

O3 PROTEIN; PROLINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; CHORDOPOXVIRINAE; CONTROLLED STUDY; DNA SEQUENCE; GENE LOCATION; GENETIC COMPLEMENTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VACCINIA VIRUS; VIRION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHROMATOGRAPHY, AFFINITY; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; POXVIRIDAE; VACCINIA VIRUS; VIRAL PLAQUE ASSAY; VIRAL PROTEINS;

MONKEYPOX VIRUS; VACCINIA VIRUS;

EID: 84857089647     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06069-11     Document Type: Article

References (30)

1. Bengali Z, Townsley AC, Moss B. 2009. Vaccinia virus strain differences in cell attachment and entry. Virology 389:132-140.
2. Bertholet C, Drillien R, Wittek R. 1985. One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proc. Natl. Acad. Sci. U. S. A. 82:2096-2100.
3. Bisht H, Weisberg AS, Moss B. 2008. Vaccinia virus L1 protein is required for cell entry and membrane fusion. J. Virol. 82:8687-8694.
4. Brown E, Senkevich TG, Moss B. 2006. Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein. J. Virol. 80:9455-9464.
5. Chakrabarti S, Sisler JR, Moss B. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23: 1094-1097.
6. Chiu WL, Lin CL, Yang MH, Tzou DLM, Chang W. 2007. Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin. J. Virol. 81:2149-2157.
7. Chung C-S, Hsiao J-C, Chang Y-S, Chang W. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparin sulfate. J. Virol. 72:1577-1585.
8. Earl PL, Moss B, Wyatt LS, Carroll MW. 1998. Generation of recombinant vaccinia viruses, p 16.17.1-16.17.19. In Ausubel FM, et al (ed), Current protocols in molecular biology, vol 2. Greene Publishing Associates& Wiley Interscience, New York, NY.
9. Horwitz BH, Burkhardt AL, Schlegel R, DiMaio D. 1988. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids. Mol. Cell. Biol. 8:4071-4078.
10. Hsiao JC, Chung CS, Chang W. 1999. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:8750-8761.
11. Huang CY, et al. 2008. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J. Virol. 82:7988-7999.
12. Husain M, Weisberg AS, Moss B. 2007. Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes. J. Virol. 81:2646-2655.
13. Izmailyan RA, Huang CY, Mohammad S, Isaacs SN, Chang W. 2006. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80:8402-8410.
14. Joklik WK. 1962. The purification of four strains of poxvirus. Virology 18:9-18.
15. Lin CL, Chung CS, Heine HG, Chang W. 2000. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74:3353-3365.
16. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535.
17. Moss B. 2007. Poxviridae: the viruses and their replication, p 2905-2946. In Knipe DM, et al (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
18. Moss B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
19. Nichols RJ, Stanitsa E, Unger B, Traktman P. 2008. The vaccinia I2L gene encodes a membrane protein with an essential role in virion entry. J. Virol. 82:10247-10261.
20. Ojeda S, Domi A, Moss B. 2006. Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex. J. Virol. 80:9822-9830.
21. Ojeda S, Senkevich TG, Moss B. 2006. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. J. Virol. 80:51-61.
22. Satheshkumar PS, Moss B. 2009. Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses. J. Virol. 83:12822-12832.
23. Senkevich TG, Moss B. 2005. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J. Virol. 79:4744-4754.
24. Senkevich TG, Ojeda S, Townsley A, Nelson GE, Moss B. 2005. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. U. S. A. 102: 18572-18577.
25. Senkevich TG, Ward BM, Moss B. 2004. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J. Virol. 78:2357-2366.
26. Townsley A, Senkevich TG, Moss B. 2005. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J. Virol. 79:10988-10998.
27. Townsley AC, Weisberg AS, Wagenaar TR, Moss B. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908.
28. von Heijne G. 1992. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J. Mol. Biol. 225:487-494.
29. Wolfe CL, Ojeda S, Moss B. 19 October 2011. Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex. J. Virol. doi:10.1128/JVI.05935-11.
30. Wong WC, Maurer-Stroh S, Eisenhaber F. 2010. More than 1,001 problems with protein domain databases: transmembrane regions, signal peptides and the issue of sequence homology. PLoS Comput. Biol. 6:e1000867.